- Home
- NEO
NEO
NeoGenomics Inc.
as of 12-11-2025 2:12pm EST
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
| Founded: | 2001 | Country: | United States |
| Employees: | N/A | City: | FORT MYERS |
| Market Cap: | 1.2B | IPO Year: | 1999 |
| Target Price: | $12.56 | AVG Volume (30 days): | 1.8M |
| Analyst Decision: | Buy | Number of Analysts: | 10 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.89 | EPS Growth: | N/A |
| 52 Week Low/High: | $4.72 - $19.11 | Next Earning Date: | 10-28-2025 |
| Revenue: | $709,162,000 | Revenue Growth: | 10.10% |
| Revenue Growth (this year): | 10.9% | Revenue Growth (next year): | 9.88% |
AI-Powered NEO Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of NeoGenomics Inc. (NEO)
EVP, GC & Business Development
Avg Cost/Share
$10.00
Shares
4,918
Total Value
$49,180.00
Owned After
43,022
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Olivo Alicia C | NEO | EVP, GC & Business Development | Oct 16, 2025 | Sell | $10.00 | 4,918 | $49,180.00 | 43,022 |
Compare NEO vs Leading Stocks
See how NEO stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "NEO NeoGenomics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.